India's new Covid rules aim to free up resources but carry risks

The moves will offer a breathing space for healthcare facilities, often overstretched in a far-flung nation of 1.4 billion, as they battle a 33-fold surge in infections over the past month

Covid testing
Krishna N Das | Reuters
2 min read Last Updated : Jan 13 2022 | 11:21 PM IST
India has eased its Covid rules on testing, quarantine and hospital admissions in a bid to free up resources for its neediest people, a strategy hailed by experts even though it carries the risk of a heavy undercount of infections and deaths.
 
The moves will offer a breathing space for healthcare facilities, often overstretched in a far-flung nation of 1.4 billion, as they battle a 33-fold surge in infections over the past month. This week, federal authorities told states to drop mandatory testing for contacts of confirmed cases unless they were old or battling other conditions, while halving the isolation period to a week and advising hospital care only for the seriously ill.
 
“Contact-tracing has been the most resource-intensive activity since the pandemic began,” said Sanjay K Rai, a professor of community medicine at AIIMS, New Delhi.
 
“That strategy did not work and wasted resources,” he added, saying serological surveys had shown it had detected only a fraction of infections. “The new one will ensure optimum utilisation of what we have got.”
 
Four Indian epidemiologists echoed Rai’s view, saying it was better to monitor the numbers of those in hospital, rather than infections, while targeting crowded spaces such as workplaces, dormitories etc with rapid testing.
 
They added that the guidelines on shorter isolation and hospital admissions were in line with global practice.
 
But some experts say the new rules could lull people into taking infections lightly until it is too late, especially in the rural areas, home to two-thirds of the population, where few seek tests unless directed by authorities.
 
“This new strategy will affect data from rural India or certain states in a disproportionate way,” said Bhramar Mukherjee, an epidemiology professor at the Universityof Michigan.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story